Saint Petersburg, Russia

Anna Sergeevna Veselova

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Joint Stock Company "Biocad". Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Anna Sergeevna Veselova. Retrieved from https://idiyas.com/inventor/anna-sergeevna-veselova

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Anna Sergeevna Veselova: Innovator in Nucleic Acid Research

Introduction

Anna Sergeevna Veselova is a prominent inventor based in Saint Petersburg, Russia. She has made significant contributions to the field of biotechnology, particularly in the area of nucleic acid research. Her innovative work has led to the development of a patent that showcases her expertise and dedication to advancing scientific knowledge.

Latest Patents

Anna holds a patent for a "Codon-Optimized Nucleic Acid Encoding SMN1 Protein." This invention is crucial for understanding and potentially treating conditions related to the SMN1 protein, which plays a vital role in motor neuron health. Her patent reflects her commitment to addressing important medical challenges through innovative solutions. She has 1 patent to her name.

Career Highlights

Anna is currently employed at Biocad, a leading biotechnology company in Russia. Her role at Biocad allows her to collaborate with other talented professionals in the field. She has been instrumental in driving research initiatives that aim to improve therapeutic outcomes for patients.

Collaborations

Anna has worked alongside notable colleagues, including Dmitriy Aleksandrovich Madera and Pavel Mikhailovich Gershovich. Their collaborative efforts have contributed to the advancement of research and development in biotechnology.

Conclusion

Anna Sergeevna Veselova is a remarkable inventor whose work in nucleic acid research is paving the way for future innovations in biotechnology. Her contributions are not only significant in the scientific community but also hold the potential to impact patient care positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…